Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 13 07:00 ET

Express News | Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

ReutersDec 13 07:00 ET

Ocular Therapeutix, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference in January 2025

Quiver QuantitativeDec 10 07:42 ET

Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $21

Moomoo NewsDec 5 12:35 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Baxter International (BAX) and Ocular Therapeutix (OCUL)

TipRanksDec 5 10:01 ET · Ratings

H.C. Wainwright Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsDec 3 06:31 ET · Ratings